Satellos Bioscience Inc Com V.ICO

Primary Symbol: ICOTF

Healthcare Biotechnology

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...

GREY:ICOTF - Post by User

Satellos Bioscience Inc Com > ICO is about to KIDNAP a HUGE established market

<< Previous

Bullboard Posts

Next >>

Comment by DrHolidayon Jul 16, 2018 3:15pm

81 Views

Post# 28322893

RE:ICO is about to KIDNAP a HUGE established market

allain250 wrote:
ICO is about to KIDNAP a HUGE established market with this new research!

DoubleBank Believes the following Scheduled Clinical Trial Reports due this July will prove Explosive concerning the Stock Price of ICO We cannot predict how high ICO stock will travel long term. Although this is a forward looking statement we have every reason to believe stock holders will see nothing but positive results concerning medical trials that have just concluded in Australia on behalf of Ico Therapeutics. The next 2 soon to be seen milestones are a follows:

1. ORAL B material pharmacokinetic data to be released in July

2. Bullous Pemphigoid Disease BP-01 material pharmacokinetic data to be released in July